Eli Lilly Research Triangle Park Manufacturing Plant
Sector: Manufacturing (Industrial) • Location: Durham, North Carolina, United States
Source: Charlotte Observer
Eli Lilly built a $474 million manufacturing plant in Research Triangle Park, North Carolina, to produce GLP-1 obesity drugs such as Mounjaro and Zepbound. The company later committed an additional $450 million to expand this site and has hired over 1,500 workers.
- Status
- Closed
- Sector
- Manufacturing (Industrial)
- Location
- Durham, North Carolina, United States of America
- Updated
- 22 Jul 2026
- Source
- Charlotte Observer
ConstructChat
Ask ConstructChat about Eli Lilly Research Triangle Park Manufacturing Plant
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | completed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Eli Lilly built a $474 million manufacturing plant in Research Triangle Park, North Carolina, to produce GLP-1 obesity drugs such as Mounjaro and Zepbound. The company later committed an additional $450 million to expand this site and has hired over 1,500 workers. |
Original sector | Pharmaceutical Manufacturing |
Budget |
Location
Country | United States of America (USA) |
State | North Carolina |
City | Durham |
Source
Source | Charlotte Observer |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial) |
Article published date | 2025-11-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project